ORIC Pharmaceuticals (ORIC) PT Raised to $15 at Oppenheimer
Tweet
Share
E-mailGet Alerts ORIC Hot Sheet
Price: $13.87 +1.09%
Rating Summary:
15 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
15 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Oppenheimer analyst Matthew Biegler raised the price target on ORIC Pharmaceuticals (NASDAQ: ORIC) to $15.00 (from $12.00) while maintaining a Outperform rating.
You May Also Be Interested In
- ORIC Pharmaceuticals (ORIC) PT Raised to $27 at H.C. Wainwright
- Chemtrade Logistics Income Fund (CHE-U:CN) (CGIFF) PT Raised to Cdn$18.50 at Desjardins
- Tata Motors Passenger Vehicles (TMPV:IN) PT Raised to INR375 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
